GAFFX
Price
$67.24
Change
+$1.05 (+1.59%)
Updated
Apr 11 closing price
Net Assets
265.04B
QMORX
Price
$19.46
Change
+$0.34 (+1.78%)
Updated
Apr 11 closing price
Net Assets
569.88M
Ad is loading...

GAFFX vs QMORX

Header iconGAFFX vs QMORX Comparison
Open Charts GAFFX vs QMORXBanner chart's image
American Funds Growth Fund of Amer F3
Price$67.24
Change+$1.05 (+1.59%)
VolumeN/A
Net Assets265.04B
AQR Large Cap Momentum Style R6
Price$19.46
Change+$0.34 (+1.78%)
VolumeN/A
Net Assets569.88M
GAFFX vs QMORX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. QMORX commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and QMORX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 265B vs. QMORX (570M). QMORX pays higher dividends than GAFFX: QMORX (0.97) vs GAFFX (0.72). GAFFX was incepted earlier than QMORX: GAFFX (8 years) vs QMORX (11 years). QMORX (0.33) is less costly to investors than GAFFX (0.30). QMORX is a more actively managed with annual turnover of: 53.00 vs. GAFFX (25.00). GAFFX has a lower initial minimum investment than QMORX: GAFFX (1000000) vs QMORX (50000000). GAFFX annual gain was more profitable for investors over the last year : -4.91 vs. QMORX (-10.40). GAFFX return over 5 years is better than : 49.10 vs. QMORX (6.01).
GAFFXQMORXGAFFX / QMORX
Total Expense Ratio0.300.3197%
Annual Report Gross Expense Ratio0.300.3391%
Fund Existence8 years11 years-
Gain YTD-9.709-9.362104%
Front LoadN/AN/A-
Min. Initial Investment1000000500000002%
Min. Initial Investment IRAN/AN/A-
Net Assets265B570M46,491%
Annual Yield % from dividends0.720.9774%
Returns for 1 year-4.91-10.4047%
Returns for 3 years7.67-11.68-66%
Returns for 5 years49.106.01818%
Returns for 10 yearsN/A0.36-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYRA0.100.02
+20.38%
Lyra Therapeutics
XP13.460.54
+4.18%
XP
CNF0.67N/A
+0.30%
CNFinance Holdings Limited
TRIN13.56-0.25
-1.81%
Trinity Capital
IART16.99-0.43
-2.47%
Integra LifeSciences Holdings Corp